Ripollés-Melchor Javier, Espinosa Ángel, Martínez-Hurtado Eugenio, Abad-Gurumeta Alfredo, Casans-Francés Rubén, Fernández-Pérez Cristina, López-Timoneda Francisco, Calvo-Vecino José María
Complutense University of Madrid and Department of Anesthesia, Hospital Universitario Infanta Leonor, Gran Vía del Este 80, 28031 Madrid, Spain; EAR (Evidence Anesthesia Review) Group.
Department of Anesthesia, Center of Vascular and Thoracic Surgery and Intensive Care, Örebro University Hospital, Sweden; EAR (Evidence Anesthesia Review) Group.
J Clin Anesth. 2016 Feb;28:105-15. doi: 10.1016/j.jclinane.2015.08.004. Epub 2015 Oct 2.
Goal-directed fluid therapy (GDHT) has been proposed as a method to reduce complications and mortality.
Meta-analysis of the effects of perioperative GDHT in adult noncardiac surgery on mortality and postoperative complications was performed using the PRISMA methodology. A systematic search was performed in MEDLINE, PubMed, EMBASE, and the Cochrane Library (last update, October 2014). Inclusion criteria were as follows: randomized clinical trials (RCTs) in which perioperative GDHT was compared with conventional fluid management in noncardiac surgery. Exclusion criteria were as follows: trauma and pediatric surgery studies. End points were mortality and number of patients with complications.
District general hospital.
Thirty-nine RCTs were initially identified, with 8 fulfilling the inclusion criteria. Two RCTs were added by manual search, resulting in 10 RCTs in the final analysis, including 1527 patients.
Those studies that fulfilled the entry criteria were examined in full and subjected to quantifiable analysis, predefined subgroup analysis (stratified by supraphysiological or physiological hemodynamic goal and by time the intervention was carried out, perioperative or postoperative), and predefined sensitivity analysis.
A significant reduction was observed in mortality associated with GDHT compared with conventional fluid therapy (risk ratio, 0.63; 95% confidence interval, 0.42-0.94; P = .02). However, no differences were found in the number of patients with complications (risk ratio, 0.75; 95% confidence interval, 0.50-1.17; P = .21), and the sensitivity analysis did not confirm the results.
This meta-analysis, with its limitations, shows that the use of perioperative GDHT may reduce postoperative mortality, but it is unable to show a reduction in the number of patients with complications.
目标导向液体治疗(GDHT)已被提议作为一种减少并发症和死亡率的方法。
采用PRISMA方法对成人非心脏手术围手术期GDHT对死亡率和术后并发症的影响进行荟萃分析。在MEDLINE、PubMed、EMBASE和Cochrane图书馆(最后更新时间为2014年10月)进行了系统检索。纳入标准如下:将围手术期GDHT与非心脏手术中的传统液体管理进行比较的随机临床试验(RCT)。排除标准如下:创伤和儿科手术研究。终点指标为死亡率和并发症患者数量。
地区综合医院。
最初识别出39项RCT,其中8项符合纳入标准。通过手动检索又增加了2项RCT,最终分析中有10项RCT,包括1527例患者。
对符合纳入标准的研究进行全面审查,并进行可量化分析、预定义亚组分析(按超生理或生理血流动力学目标以及干预实施时间,围手术期或术后进行分层)和预定义敏感性分析。
与传统液体治疗相比,观察到GDHT相关的死亡率显著降低(风险比,0.63;95%置信区间,0.42 - 0.94;P = 0.02)。然而,并发症患者数量没有差异(风险比,0.75;95%置信区间,0.50 - 1.17;P = 0.21),敏感性分析未证实该结果。
这项存在局限性的荟萃分析表明,围手术期使用GDHT可能降低术后死亡率,但无法显示并发症患者数量的减少。